Healthcare provider profile · identity verified

Smita Sikhrakar, AGPCNP

Nurse Practitioner · RICHLAND, WA · NPI 1124596762

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	716	194
Levothyroxine Sodium	Levothyroxine Sodium	530	147
Amlodipine Besylate	Amlodipine Besylate	423	119
Gabapentin	Gabapentin	420	121
Losartan Potassium	Losartan Potassium	410	115
Lisinopril	Lisinopril	367	98
Omeprazole	Omeprazole	339	98
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	242	65
Metoprolol Succinate	Metoprolol Succinate	215	68
Donepezil Hcl	Donepezil Hcl	209	42
Tramadol Hcl	Tramadol Hcl	209	48
Potassium Chloride	Potassium Chloride	197	64
Simvastatin	Simvastatin	186	50
Metformin Hcl	Metformin Hcl	183	44
Furosemide	Furosemide	168	52
Sertraline Hcl	Sertraline Hcl	159	40
Pantoprazole Sodium	Pantoprazole Sodium	157	43
Trazodone Hcl	Trazodone Hcl	155	42
Eliquis	Apixaban	149	37
Hydrochlorothiazide	Hydrochlorothiazide	147	43
Zolpidem Tartrate	Zolpidem Tartrate	146	23
Pravastatin Sodium	Pravastatin Sodium	142	40
Citalopram Hbr	Citalopram Hydrobromide	132	33
Metoprolol Tartrate	Metoprolol Tartrate	124	42
Alprazolam	Alprazolam	114	32
Clopidogrel	Clopidogrel Bisulfate	105	25
Duloxetine Hcl	Duloxetine Hcl	102	30
Allopurinol	Allopurinol	100	28
Alendronate Sodium	Alendronate Sodium	97	25
Escitalopram Oxalate	Escitalopram Oxalate	97	28
Rosuvastatin Calcium	Rosuvastatin Calcium	92	34
Tamsulosin Hcl	Tamsulosin Hcl	90	27
Torsemide	Torsemide	88	27
Famotidine	Famotidine	83	28
Fluticasone Propionate	Fluticasone Propionate	81	37
Pregabalin	Pregabalin	79	19
Memantine Hcl	Memantine Hcl	78	20
Triamcinolone Acetonide	Triamcinolone Acetonide	78	47
Prednisone	Prednisone	75	48
Ozempic	Semaglutide	74	17
Tizanidine Hcl	Tizanidine Hcl	71	18
Lovastatin	Lovastatin	69	20
Montelukast Sodium	Montelukast Sodium	67	17
Carvedilol	Carvedilol	63	16
Oxybutynin Chloride Er	Oxybutynin Chloride	63	16
Quetiapine Fumarate	Quetiapine Fumarate	63	18
Albuterol Sulfate Hfa	Albuterol Sulfate	61	29
Ondansetron Odt	Ondansetron	61	25
Ezetimibe	Ezetimibe	60	18
Glimepiride	Glimepiride	60	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	60	13
Metformin Hcl Er	Metformin Hcl	59	18
Hydralazine Hcl	Hydralazine Hcl	58	15
Synthroid	Levothyroxine Sodium	58	16
Atenolol	Atenolol	55	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	14
Mirtazapine	Mirtazapine	53	17
Ropinirole Hcl	Ropinirole Hcl	49	12
Bupropion Xl	Bupropion Hcl	46	16
Fluoxetine Hcl	Fluoxetine Hcl	46	14
Spironolactone	Spironolactone	44	12
Ibandronate Sodium	Ibandronate Sodium	43	11
Paroxetine Hcl	Paroxetine Hcl	43	suppressed
Meloxicam	Meloxicam	41	17
Nifedipine Er	Nifedipine	39	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	38	13
Baclofen	Baclofen	38	18
Loperamide	Loperamide Hcl	38	11
Oxycodone Hcl	Oxycodone Hcl	37	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Finasteride	Finasteride	33	suppressed
Jardiance	Empagliflozin	33	11
Glipizide Er	Glipizide	30	suppressed
Cephalexin	Cephalexin	29	24
Doxycycline Hyclate	Doxycycline Hyclate	29	23
Nortriptyline Hcl	Nortriptyline Hcl	28	suppressed
Estradiol	Estradiol	27	14
Lorazepam	Lorazepam	27	11
Azithromycin	Azithromycin	26	25
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Nystatin	Nystatin	26	16
Spiriva Handihaler	Tiotropium Bromide	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	22
Buspirone Hcl	Buspirone Hcl	23	suppressed
Fluconazole	Fluconazole	23	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	12
Olanzapine	Olanzapine	23	suppressed
Bupropion Hcl	Bupropion Hcl	22	suppressed
Liothyronine Sodium	Liothyronine Sodium	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	12
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Valsartan	Valsartan	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	15
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	18
Diltiazem Hcl	Diltiazem Hcl	19	suppressed
Folic Acid	Folic Acid	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Primidone	Primidone	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Temazepam	Temazepam	17	suppressed
Glipizide	Glipizide	16	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Pen Needle	Pen Needle, Diabetic	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	12
Clonidine Hcl	Clonidine Hcl	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Diazepam	Diazepam	14	suppressed
Risperidone	Risperidone	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Lactulose	Lactulose	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nateglinide	Nateglinide	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Desloratadine	Desloratadine	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Tramadol Hcl Er	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error